跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vial - TGA Drug Approval Details
Approvals
/
TGA
/
ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vial
Approved
STANDARD
ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vial
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
00a0de2ba763f88f
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
00a0de2ba763f88f
Product Name
ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vial
Artg Id
100385
Artg Name
ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vial
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2005-04-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/fff99473ff0138e81c0b7b3b1c78729e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/17fa12580409c0d11ea1243a003b6d6d.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
00a0de2ba763f88f
Type
Standard
Back to TGA Approvals